Loading...
IRMD logo

IRADIMED Community

NasdaqGM:IRMD Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 12 Fair Values set on narratives written by author

Community Investing Ideas

IRMD logo
IRADIMED

FDA Approval Will Unlock Broad MRI Market Expansion

Key Takeaways Enhanced usability and technology in the new MRI-compatible IV pump are expected to drive major replacement cycles and expand the customer base. Aging populations and higher MRI volumes support sustained demand, while operational investments and strong pricing power boost margins and revenue visibility.

View narrative
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
US$73.5
4.6% overvalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
10.24% p.a.
Profit Margin
27.25%
Future PE
38.53x
Share price in 2028
US$84.94